| Prev Close: | 0.36 |
|---|---|
| Open: | 0.36 |
| Bid: | 0.33 |
| Ask: | 0.37 |
| 1y Target Est: | N/A |
| Beta: | N/A |
| Next Earnings Date: | N/A |
| Day's Range: | 0.36 - 0.36 |
|---|---|
| 52wk Range: | 0.25 - 0.64 |
| Volume: | 5,000 |
| Avg Vol (3m): | 19,376 |
| Market Cap: | 20.52M |
| P/E (ttm): | N/A |
| EPS (ttm): | N/A |
| Div & Yield: | N/A (N/A) |
Headlines
- Amorfix to investigate lung cancer misfolded proteins for therapeutic interventionCNW Group(Thu Apr 25)
- Amorfix to investigate lung cancer misfolded proteins for therapeutic interventionCNW Group(Thu Apr 25)
- Amorfix closes second tranche of private placement offeringCNW Group(Mon Apr 22)
- Amorfix closes second tranche of private placement offeringCNW Group(Mon Apr 22)
- Amorfix announces breakthrough scientific discovery and provides update for its ovarian cancer therapeutic antibody programCNW Group(Tue Apr 9)
- Amorfix announces breakthrough scientific discovery and provides update for its ovarian cancer therapeutic antibody programCNW Group(Tue Apr 9)
- Amorfix closes private placement offeringCNW Group(Fri Apr 5)
- Amorfix closes private placement offeringCNW Group(Fri Apr 5)
- Amorfix Chief Science Officer to present latest on ovarian cancer therapeutic program at AACR 2013CNW Group(Wed Apr 3)
- Amorfix Chief Science Officer to present latest on ovarian cancer therapeutic program at AACR 2013CNW Group(Wed Apr 3)
- Amorfix announces progress on ALS programCNW Group(Wed Mar 20)
- Amorfix announces progress on ALS programCNW Group(Wed Mar 20)
- Amorfix Closes Private Placement OfferingCNW Group(Thu Feb 21)
- Amorfix Closes Private Placement OfferingCNW Group(Thu Feb 21)
- Amorfix announces third quarter fiscal 2013 results and financingCNW Group(Thu Feb 14)
Press Releases
- Amorfix to investigate lung cancer misfolded proteins for therapeutic interventionCNW Group(Thu Apr 25)
- Amorfix closes second tranche of private placement offeringCNW Group(Mon Apr 22)
- Amorfix announces breakthrough scientific discovery and provides update for its ovarian cancer therapeutic antibody programCNW Group(Tue Apr 9)
Must Read
- Global shares grind higher, gold pauses from big losing streakReuters(1969-12-31T18:59:59GMT-05:00)
- Chesapeake Energy hires Anadarko executive as CEOReuters(1969-12-31T18:59:59GMT-05:00)
- Despite talk of Fed changing tack, investors have so far refrained from big profit-takingThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
- 2 men arrested in killing of Las Vegas teen who refused to give up his iPadThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
- Gasoline prices at US pumps 11 cents over past 2 weeksThe Canadian Press(1969-12-31T18:59:59GMT-05:00)